Nicotine Polacrilex en es it fr

Nicotine Polacrilex Brand names, Nicotine Polacrilex Analogs

Nicotine Polacrilex Brand Names Mixture

  • No information avaliable

Nicotine Polacrilex Chemical_Formula


Nicotine Polacrilex RX_link

Nicotine Polacrilex fda sheet

Nicotine_Polacrilex FDA

Nicotine Polacrilex msds (material safety sheet)

Nicotine_Polacrilex MSDS

Nicotine Polacrilex Synthesis Reference

Pinner, Ber. 26, 294 (1893)

Nicotine Polacrilex Molecular Weight

162.232 g/mol

Nicotine Polacrilex Melting Point

-79 oC

Nicotine Polacrilex H2O Solubility

1 g/mL

Nicotine Polacrilex State


Nicotine Polacrilex LogP


Nicotine Polacrilex Dosage Forms

Gum; Inhaler; Patch

Nicotine Polacrilex Indication

For the relief of nicotine withdrawal symptoms and as an aid to smoking cessation.

Nicotine Polacrilex Pharmacology

Nicotine, the primary alkaloid in tobacco products binds stereo-selectively to nicotinic-cholinergic receptors on autonomic ganglia, the adrenal medulla, neuromuscular junctions and in the brain. Nicotine exerts two effects, a stimulant effect exerted at the locus ceruleus and a reward effect in the limbic system. Itranvenous administration of nicotine causes release of acetylcholine, norepinephrine, dopamine, serotonine, vasopressin, beta-endorphin and ACTH. Nicotine is a highly addictive substance. Nicotine also induces peripheral vasoconstriction, tachycardia and elevated blood pressure. Nicotine inhalers and patches are used to treat smoking withdrawl syndrome. Nicotine is classified as a stimulant of autonomic ganglia.

Nicotine Polacrilex Absorption

Absorption of nicotine through the buccal mucosa is relatively slow and the high and rapid rise followed by the decline in nicotine arterial plasma concentrations seen with cigarette smoking are not achieved with the inhaler. About 10% of absorbed nicotine is excreted unchanged in urine.

Nicotine Polacrilex side effects and Toxicity

Symptoms of overdose include nausea, abdominal pain, vomiting, diarrhea, diaphoresis, flushing, dizziness, disturbed hearing and vision, confusion, weakness, palpitations, altered respiration and hypotension. LD50= 24 mg/kg (orally in mice).

Nicotine Polacrilex Patient Information

A patient information sheet is included in the package of NICOTROL Inhaler cartridges dispensed to the patient. Patients should be encouraged to read the information sheet carefully and to ask their physician and pharmacist about the proper use of the product .

Patients must be advised to keep both used and unused cartridges out of the reach of children and pets.

Nicotine Polacrilex Organisms Affected

Humans and other mammals